Please use this identifier to cite or link to this item:
https://hdl.handle.net/1/149
Title: | Longitudinal analysis of performance of estimated glomerular filtration rate as renal function declines in chronic kidney disease | Authors: | Lee, Darren ;Levin, Adeera ;Roger, Simon D ;McMahon, L.P. | Issue Date: | Jan-2009 | Source: | Volume 24, Issue 1, pp. 109-116 | Journal title: | Nephrology Dialysis Transplantation | Abstract: | BACKGROUND: Numerous studies have assessed the accuracy of equations estimating glomerular filtration rate (eGFR) from serum creatinine in individuals with chronic kidney disease (CKD) in cross-sectional studies. Limited literature exists, however, on the consistency of performance of these equations in longitudinal studies as renal function declines. METHODS: Radionucleotide-measured GFR from 155 predialysis patients with stage 3-5 CKD was compared with eGFR derived from four equations [6-variable Modification of Diet in Renal Disease (6-MDRD), 4-variable MDRD (4-MDRD), Cockcroft-Gault (CG) and Cockcroft-Gault equations corrected for body surface area (CGC)] at baseline, 12 and 24 months. Bias (difference between eGFR and measured GFR) was used as a measure of performance. Restricted Maximum Likelihood (REML) models were used to identify variables potentially affecting the performance of estimating equations across time. RESULTS: Mean measured GFR (+/-SD) at baseline, 12 and 24 months was 25.9 +/- 10.7, 23.1 +/- 10.6 and 20.3 +/- 10.1 mL/min/1.73 m(2), respectively. There was a statistically significant negative association between bias and GFR for all four estimates (range: -0.76 to -0.71, P < 0.001 for all), indicating worsening underestimation and overestimation at higher and lower GFR, respectively. This negative association significantly reduced over the 24 months (P < 0.001); however, this was largely due to persistent underestimation of eGFR from individuals with GFR >50 mL/min/1.73 m(2). For those with a baseline GFR <50 mL/min/1.73 m(2), the change in bias for any of the four equations over 24 months was <or=1.1 mL/min/1.73 m(2), suggesting relatively preserved performance with time. The MDRD equations showed a sustained advantage in estimating renal function that was more evident as GFR declined. CONCLUSION: GFR estimates are inexpensive and show an acceptable longitudinal performance for monitoring CKD patients with GFR <50 mL/min/1.73 m(2). Inaccuracies appear more substantial above this level of GFR, and care with interpretation is required. | Description: | Open Access: http://ndt.oxfordjournals.org/content/24/1/109.short | URI: | https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/149 | DOI: | 10.1093/ndt/gfn477 | Pubmed: | http://www.ncbi.nlm.nih.gov/pubmed/18755849 | ISSN: | 0931-0509 | Publicaton type: | Journal Article | Keywords: | Kidney Disease Drug Therapy |
Study or Trial: | Randomized Controlled Clinical Trial/Controlled Clinical Trial |
Appears in Collections: | Renal Medicine |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.